The recent disruptions in global supply have highlighted the value of securing critical medications like Ivermectin. Relying on overseas vendors exposes countries to significant vulnerabilities, including delivery delays, expense fluctuations, and even political threats. Transitioning towards domestic production of Ivermectin offers a multitude of